(24/7 MARKET NEWS) – Virax Biolabs Group Limited (NASDAQ: VRAX) and Cosmos Holdings Inc. (NASDAQ: COSM) are both in the green after they announced a new exclusive distribution agreement.
We first covered Virax on Tuesday and it’s now trading at $3.51, 47 cents higher (+15.46%), on 2.08 million shares traded in the premarket. This one doesn’t have a buy-and-hold feel about it, as it’s well off its recent IPO high of $29.00, but, if it can break through Tuesdays $3.76 high, on strong volume, it could try to challenge its early September price levels.
Cosmos is at $0.30, up 7 cents (+32.57%), on 1.35 million premarket shares. It’s near the lows of its 52-week range of $0.2222 to $6.00 and has resistance at the 35 and 40 cent levels.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.
